Pretax income is the income that a company earns before paying income taxes. BioLife Solutions's pretax income for the
three
months ended in Mar. 2024 was $-10.1 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-62.7 Mil.
BioLife Solutions's pretax margin was -31.80%.
During the past 13 years, BioLife Solutions's highest Pretax Margin was -2.66%. The lowest was -126.66%. And the median was -49.79%.
BioLife Solutions Pre-Tax Income Historical Data
The historical data trend for BioLife Solutions's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioLife Solutions's Pre-Tax Income
For the Medical Instruments & Supplies subindustry, BioLife Solutions's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioLife Solutions's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BioLife Solutions's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where BioLife Solutions's Pre-Tax Income falls into.
BioLife Solutions Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
BioLife Solutions's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-62.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioLife Solutions (NAS:BLFS) Pre-Tax Income Explanation
BioLife Solutions's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as
During the past 13 years, BioLife Solutions's highest Pretax Margin was -2.66%. The lowest was -126.66%. And the median was -49.79%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioLife Solutions Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of BioLife Solutions's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
BioLife Solutions (BioLife Solutions) Business Description
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BLFS has been successfully added to your 